Home				Orphan Diseases Drug Development Weekly - Y2007 week 02
DATE	SOURCE	OTHER PARTY INVOLVED	INDICATION(S)	HEADLINES - CLICK TO VIEW FULL RELEASE
01/12/07	Jazz Pharmaceuticals (US)	Valeant Pharmaceuticals (US)	Narcolepsy - cataplexy	Jazz Pharmaceuticals Signs Licensing Agreement With Valeant Pharmaceuticals for Canadian Marketing Rights to Xyrem(R)
01/12/07	Pipex Pharmaceuticals (US)	Effective Pharmaceuticals (US)	Acute refractory pouchitis	Pipex Pharmaceuticals Acquires Minority Interest in Its Effective Pharmaceuticals Subsidiary
01/12/07	Point Therapeutics (US)		Pancreatic cancer (metastatic)	Point Therapeutics Provides Preliminary Results from Phase 2 Metastatic Pancreatic Cancer Study
01/12/07	Valeant Pharmaceuticals (US)	Jazz Pharmaceuticals (US)	Narcolepsy - cataplexy	Valeant Pharmaceuticals Signs Licensing Agreement for Canadian Rights to (C)Xyrem® (Sodium Oxybate) from Jazz Pharmaceuticals
01/11/07	AnGes MG (JP)	Vical (US)	Melanoma (metastatic)	AnGes MG, Vical to Start Phase III Clinical Trial of Allovectin for Gene Therapy
01/11/07	Chelsea Therapeutics International (US)	Dainippon Sumitomo Pharma (JP)	Neurogenic orthostatic hypotension	Chelsea Therapeutics Announces Results of European Phase IIb Trial of Droxidopa
01/11/07	Shire (UK)		Hunter syndrome	The European Commission Approves First and Only Enzyme Replacement Therapy for Hunter Syndrome
01/10/07	EMEA - COMP (UK)	ACE Pharmaceuticals (NL)	Malaria	Committee for Orphan Medicinal Products January 2007 Meeting
01/10/07	EMEA - COMP (UK)	Immatics Biotechnologies (DE)	Renal cell carcinoma	Committee for Orphan Medicinal Products January 2007 Meeting
01/10/07	EMEA - COMP (UK)	Santhera Pharmaceuticals (DE)	Leber's hereditary optic neuropathy	Committee for Orphan Medicinal Products January 2007 Meeting
01/10/07	EMEA - COMP (UK)	Pharming Group (NL)	Delayed graft function post organ transplantation	Committee for Orphan Medicinal Products January 2007 Meeting
01/10/07	Genentech (US)		Various	Genentech Announces Full Year and Fourth Quarter 2006 Results
01/10/07	Insmed (US)	Cephalon (US)	Amyotrophic lateral sclerosis	Italian Ministry of Health Requests IPLEXTM for Treatment of ALS (Lou Gehrig’s Disease)
01/10/07	Viralytics (US)		Melanoma (metastatic)	Ethics Committee Approval to conduct a Phase I study in Breast, Prostate and Melanoma Cancer patients using CAVATAKTM administered intravenously
01/09/07	Actelion (CH)	CoTherix (US)	Pulmonary arterial hypertension	Actelion Ltd. Announces Successful Completion of its Cash Tender Offer for Shares of CoTherix, Inc.
01/09/07	Anthera Pharmaceuticals (US)		Acute chest syndrome	Anthera Receives IND Approval from FDA to Begin Phase 2 'IMPACTS' Trial With A-001 for Prevention of Acute Chest Syndrome in Patients with Sickle Cell…
01/09/07	Biogen Idec (US)		Multiple sclerosis	Biogen Idec Initiates Phase III Clinical Program of Oral Compound BG-12 for Multiple Sclerosis
01/09/07	Genzyme (US)		Various	Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude Productive Year
01/09/07	GlaxoSmithKline (US)	Praecis Pharmaceuticals (US)	Non-Hodgkin's lymphoma	GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS
01/09/07	Medarex (US)	BioWa (US)	Hodgkin's disease (relapsed or refractory)	BioWa and Medarex Announce Allowance of Investigational New Drug Application for Second-Generation Anti-CD30 Antibody (MDX-1401) Enhanced…
01/09/07	sanofi-aventis (FR)	sanofi pasteur (FR)	Meningitis	Menactra(TM) vaccine available for meningitis prevention in Canada
01/08/07	Allos Therapeutics (US)		Lymphoma (peripheral T-cell)	Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 Trial of Its Novel Antifolate PDX in Patients With Peripheral T-cell…
01/08/07	Emory Eye Center (US)		Retinitis pigmentosa	Traditional Chinese Medicine Component May Yield Help in Retinal Degenerations
01/08/07	Human Genome Sciences (US)		Various	Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2007 Goals at JPMorgan Healthcare…
01/08/07	Osiris Therapeutics (US)		Crohn disease	Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn’s Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
01/08/07	Provectus Pharmaceuticals (US)		Melanoma (metastatic)	Provectus Receives Orphan Drug Designation from FDA for Anti-Cancer Agent PV-10 for the Treatment Of Metastatic Melanoma
01/08/07	Seattle Genetics (US)	Genentech (US)	Various	Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40
01/08/07	Vertex Pharmaceuticals (US)		Cystic fibrosis	Vertex Pharmaceuticals Announces 2007 Business Objectives at 25th Annual JPMorgan Healthcare Conference
01/08/07	Xanthus Pharmaceuticals (US)		Acute myeloid leukemia	Xanthus Receives Orphan Drug Designation of Xanafide for the Treatment Of AML